Daniel J. Brennan is Director of MADRIGAL PHARMACEUTICALS, INC.. Currently has a direct ownership of 967 shares of MDGL, which is worth approximately $334,320. The most recent transaction as insider was on Aug 01, 2025, when has been sold 967 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 967
n/a 3M change
n/a 12M change
Total Value Held $334,320

Daniel J. Brennan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 01 2025
BUY
Grant, award, or other acquisition
-
967 Added 50.0%
967 Common Stock

Also insider at

BSX
BOSTON SCIENTIFIC CORP Healthcare
NUAN
Nuance Communications, Inc. Technology
WAT
WATERS CORP Healthcare
DJB

Daniel J. Brennan

Director
Marlborough, MA

Track Institutional and Insider Activities on MDGL

Follow MADRIGAL PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MDGL shares.

Notify only if

Insider Trading

Get notified when an Madrigal Pharmaceuticals, Inc. insider buys or sells MDGL shares.

Notify only if

News

Receive news related to MADRIGAL PHARMACEUTICALS, INC.

Track Activities on MDGL